Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 20/20 | 0.87 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.71 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.71 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.71 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.71 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.71 |
| ▸ | F2 | P00734 | 1/20 | 0.71 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19230362 | 1.00 | F10 (0.87) | F10CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL793663 | 0.96 | F10 (0.81) | F10CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL793664 | 0.96 | F10 (0.81) | F10CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL18314269 | 0.95 | F10 (0.80) | F10CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL20057703 | 0.94 | F10 (0.81) | F10CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL19380050 | 0.91 | F10 (0.79) | F10CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL19230361 | 0.89 | F10 (0.71) | F10CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL806187 | 0.88 | F10 (0.74) | F10CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL16467069 | 0.87 | F10 (0.73) | F10CYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL14838774 | 0.87 | F10 (0.73) | F10CYP1A2CYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114031617-B | Preparation method of phthalic diamide compound | 北京鑫开元医药科技有限公司 | 2022-06-03 | — | — | CN | disclosed |
| CN-114031617-A | Preparation method of phthalic diamide compound | 北京鑫开元医药科技有限公司 | 2022-02-11 | — | — | CN | disclosed |
| EP-3309158-A1 | CRYSTALLINE FORM K OF RIVAROXABAN AND PROCESS FOR ITS PREPARATION | Farma GRS, d.o.o. (SI) | 2018-04-18 | — | — | EP | disclosed |
| EP-2935255-B1 | A PROCESS FOR PREPARATION OF RIVAROXABAN | FARMA GRS D O O (SI) | 2017-08-16 | — | — | EP | disclosed |
| WO-2014096214-A1 | A PROCESS FOR PREPARATION OF RIVAROXABAN | FARMA GRS, D.O.O. (SI) | 2014-06-26 | — | — | WO | disclosed |
| US-20130253187-A1 | Process for Determining the Suitability for Distribution of a Batch of Thiophene-2-Carboxamide Derivative | MEDICHEM, S.A. (ES) | 2013-09-26 | — | — | US | disclosed |
| US-20130253187-A1 | Process for Determining the Suitability for Distribution of a Batch of Thiophene-2-Carboxamide Derivative | MEDICHEM, S.A. (ES) | 2013-09-26 | — | — | US | disclosed |
| WO-2012035057-A2 | PROCESS FOR DETERMINING THE SUITABILITY FOR DISTRIBUTION OF A BATCH OF A THIOPHENE-2-CARBOXAMIDE DERIVATIVE | MEDICHEM S.A. (ES) | 2012-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130253187-A1 | Process for Determining the Suitability for Distribution of a Batch of Thiophene-2-Carboxamide Derivative | CYP2C9, CYP3A5, CYP3A43 | F10 51/4885CYP1A2 6/4885CYP3A4 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.